Gibraltar Capital Management, Inc. / BMY
Gibraltar Capital Management, Inc.’s Bristol-Myers Squibb Co Position
Does Gibraltar Capital Management, Inc. own Bristol-Myers Squibb Co (BMY)? Yes — 138.6K shares worth $8M (+1.45% of its 13F portfolio) as of Q1 2026, up from 126.8K shares the prior filed quarter.
Position Value
$8M
Q1 2026
Shares
138.6K
% of Portfolio
+1.45%
Quarters Held
29
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 138.6K | $8M | +1.45% |
| Q4 2025 | 126.8K | $7M | +1.16% |
| Q3 2025 | 127.3K | $6M | +1.03% |
| Q2 2025 | 121.5K | $6M | +1.10% |
| Q1 2025 | 118.4K | $7M | +1.56% |
| Q4 2024 | 116.9K | $7M | +2.92% |
| Q3 2024 | 115.3K | $6M | +2.68% |
| Q2 2024 | 112.2K | $5M | +2.11% |
| Q1 2024 | 110.1K | $6M | +2.78% |
| Q4 2023 | 77.4K | $4M | +1.69% |
| Q3 2023 | 93.2K | $5M | +2.40% |
| Q2 2023 | 91.1K | $6M | +2.58% |
| Q1 2023 | 89.4K | $6M | +2.90% |
| Q4 2022 | 88.2K | $6M | +3.01% |
| Q3 2022 | 87.3K | $6M | +3.18% |
| Q2 2022 | 91.4K | $7M | +3.42% |
| Q1 2022 | 104.9K | $8M | +3.19% |
| Q4 2021 | 104.2K | $6M | +2.94% |
| Q3 2021 | 108.2K | $6M | +3.25% |
| Q2 2021 | 104.7K | $7M | +3.49% |
| Q1 2021 | 98.4K | $6M | +3.19% |
| Q4 2020 | 84.3K | $5M | +3.12% |
| Q3 2020 | 83.5K | $5M | +3.51% |
| Q2 2020 | 88.7K | $5M | +3.83% |
| Q1 2020 | 89.6K | $5M | +3.56% |
| Q4 2019 | 91.7K | $6M | +3.54% |
| Q3 2019 | 80.5K | $4M | +3.08% |
| Q2 2019 | 75.4K | $3M | +3.52% |
| Q1 2019 | 74.5K | $4M | +3.57% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gibraltar Capital Management, Inc.’s full portfolio or all institutional holders of BMY.